Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Predator pressure and public lands policy were front and center at CattleCon.
Dr. Peter Beetham, interim CEO of Cibus, joined us to discuss the status of EU gene-editing deregulation and its potential implications for agriculture.
Representative Henry Cuellar (D-TX), who sits on the U.S. House Appropriations Committee, spoke exclusively with RFD NEWS about what Congress is doing to address screwworm concerns, including funding for a sterile fly production facility in Mexico.
HHS Secretary Robert Kennedy calls on cattle producers to retain breeding cows while Ivomec receives emergency authorization to prevent New World screwworm.
The House Agriculture Committee is set to debate a new, “skinny” Farm Bill at the end of February, according to a release from Committee Chairman Rep. Glenn “GT” Thompson.
Regulatory uncertainty could slow the growth of fiber and grain hemp unless implementation is delayed.
